News
The Food and Drug Administration has approved a highly effective new HIV prevention medication, known as Yeztugo. In clinical ...
54m
Asianet Newsable on MSNGilead Earns Analyst Praise As FDA Clears Yeztugo For Biannual HIV PreventionAnalysts at Oppenheimer, BMO, Morgan Stanley, and Mizuho weighed in with positive long-term views, though Oppenheimer flagged ...
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...
On Wednesday, the Food and Drug Administration approved a highly effective, injectable drug to help prevent the transmission ...
The U.S. Food and Drug Administration approved an HIV prevention medication that has been proven highly effective in clinical ...
Men, women, gay, straight – it really just kinds of expands the opportunity for prevention’ Source: Twice-a-year shot to prevent HIV could stop transmission — if people can get it – Zimbabwe News Now ...
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...
The injectable HIV prevention treatment Yetzugo, made by Gilead Sciences, has received FDA approval, offering a twice-yearly ...
The breakthrough double injection won’t be cheap in the US, although scientists argue it could (and should) be.
FDA approves Yeztugo HIV prevention injection showing 96% efficacy in clinical trials, but $14,000 cost creates significant access barriers for patients.
In two recent studies, this new shot reportedly nearly eliminated new infections in people at substantial risk of HIV.
A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results